We currently support a number of clinical research studies, including:
BILAG – Biologics prospective cohort in systemic lupus erythematosus study
BRAGGSS – Aims to find out whether clinical, serological (Serum – is the fluid obtained when blood is separated into its solid and liquid components after it has been allowed to clot. It contains antibodies, which are made by the immune system to defend against infection), genetic and psychological factors influence rheumatoid arthritis or response to treatment
BSRBR RA national register – The register aims to find out if there are any long term side effects or health problems for rheumatoid arthritis patients on biologic therapies – find out more
RAMS – Rheumatoid arthritis methotrexate starters study. The study’s aim is to see whether researchers can predict which patients will do well and who will have to stop using common rheumatoid arthritis medication, methotrexate based on blood test results
Prevent RA – Pre-clinical evaluation of novel targets in rheumatoid arthritis, for relatives of patients with RA. The study will look at a number of factors for each person, including their genes, immune system and lifestyle environment to understand what makes people more likely or less likely to develop rheumatoid arthritis. Register for the study
LEAP – A study for patients with lupus and other connective tissue disease
OUTPASS – Study led by The University of Manchester. The study aims to find out whether clinical, serological (Serum is the fluid obtained when blood is separated into its solid and liquid components after it has been allowed to clot. It contains antibodies, which are made by the immune system to defend against infection), genetic and psychological factors influence Psoriatic Arthritis or response to treatment.
For more information about these studies and other research at The Kellgren Centre for Rheumatology please contact Senior Research Nurse rheumatology.research@mft.nhs.uk or 0161 276 4358.
